Follow
Ahmed El Kerdawy
Ahmed El Kerdawy
Pharmaceutical chemistry department - Faculty of Pharmacy - Cairo University
Verified email at pharma.cu.edu.eg - Homepage
Title
Cited by
Cited by
Year
Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors
MA Abdullaziz, HT Abdel-Mohsen, AM El Kerdawy, FAF Ragab, MM Ali, ...
European journal of medicinal chemistry 136, 315-329, 2017
972017
Increasing the binding affinity of VEGFR-2 inhibitors by extending their hydrophobic interaction with the active site: Design, synthesis and biological evaluation of 1 …
W Eldehna, S Abou-Seri, AM El Kerdawy, RR Ayyad, AM Hamdy, ...
European Journal of Medicinal Chemistry 113, 50-62, 2016
812016
New thiazol-hydrazono-coumarin hybrids targeting human cervical cancer cells: Synthesis, CDK2 inhibition, QSAR and molecular docking studies
SS Abd El-Karim, YM Syam, AM El Kerdawy, TM Abdelghany
Bioorganic chemistry 86, 80-96, 2019
722019
Design, synthesis and biological evaluation of novel pyrazole sulfonamide derivatives as dual COX-2/5-LOX inhibitors
EM Gedawy, AE Kassab, AM El Kerdawy
European Journal of Medicinal Chemistry 189, 112066, 2020
692020
Directional noncovalent interactions: repulsion and dispersion
A El Kerdawy, JS Murray, P Politzer, P Bleiziffer, A Hesselmann, ...
Journal of Chemical Theory and Computation 9 (5), 2264-2275, 2013
672013
Design and Synthesis of some new 2, 4, 6-trisubstituted quinazoline EGFR inhibitors as targeted anticancer agents
HA Allam, EE Aly, AK Farouk, AM El Kerdawy, E Rashwan, SES Abbass
Bioorganic Chemistry 98, 103726, 2020
602020
Novel oxindole/benzofuran hybrids as potential dual CDK2/GSK-3β inhibitors targeting breast cancer: design, synthesis, biological evaluation, and in silico studies
WM Eldehna, ST Al-Rashood, T Al-Warhi, RO Eskandrani, A Alharbi, ...
Journal of Enzyme Inhibition and Medicinal Chemistry 36 (1), 271-286, 2021
592021
Type IIA-Type IIB protein tyrosine kinase inhibitors hybridization as an efficient approach for potent multikinase inhibitor development: Design, synthesis, anti-proliferative …
WM Eldehna, AM El Kerdawy, GH Al-Ansary, ST Al-Rashood, MM Ali, ...
European Journal of Medicinal Chemistry 163, 37-53, 2019
562019
Synthesis and anticonvulsant activity of certain substituted furochromone, benzofuran and flavone derivatives
FAF Ragab, NAM El-Sayed, AAHM Eissa, AM El Kerdawy
Chemical and Pharmaceutical Bulletin 58 (9), 1148-1156, 2010
482010
Synthesis, biological evaluation and in silico studies of certain oxindole–indole conjugates as anticancer CDK inhibitors
T Al-Warhi, AM El Kerdawy, N Aljaeed, OE Ismael, RR Ayyad, ...
Molecules 25 (9), 2031, 2020
472020
Novel potent substituted 4-amino-2-thiopyrimidines as dual VEGFR-2 and BRAF kinase inhibitors
HT Abdel-Mohsen, MA Omar, AM El Kerdawy, AEE Mahmoud, MM Ali, ...
European Journal of Medicinal Chemistry 179, 707-722, 2019
442019
Targeting receptor tyrosine kinase VEGFR-2 in hepatocellular cancer: rational design, synthesis and biological evaluation of 1, 2-disubstituted benzimidazoles
HT Abdel-Mohsen, MA Abdullaziz, AM El Kerdawy, FAF Ragab, ...
Molecules 25 (4), 770, 2020
412020
Novel benzothiazole-based dual VEGFR-2/EGFR inhibitors targeting breast and liver cancers: Synthesis, cytotoxic activity, QSAR and molecular docking studies
EA Abd El-Meguid, AM Naglah, GO Moustafa, HM Awad, AM El Kerdawy
Bioorganic & Medicinal Chemistry Letters 58, 128529, 2022
382022
Anticancer activities, molecular docking and structure–activity relationship of novel synthesized 4H-chromene, and 5H-chromeno[2,3-d]pyrimidine candidates
AH Halawa, MM Elaasser, AM El Kerdawy, AMAI Abd El-Hady, HA Emam, ...
Medicinal Chemistry Research 26, 2624-2638, 2017
382017
Identification of the beer component hordenine as food-derived dopamine D2 receptor agonist by virtual screening a 3D compound database
T Sommer, H Hübner, A El Kerdawy, P Gmeiner, M Pischetsrieder, T Clark
Scientific reports 7 (1), 44201, 2017
372017
Sulfonamide-based 4-anilinoquinoline derivatives as novel dual Aurora kinase (AURKA/B) inhibitors: Synthesis, biological evaluation and in silico insights
MM Al-Sanea, A Elkamhawy, S Paik, K Lee, AM El Kerdawy, BSN Abbas, ...
Bioorganic & medicinal chemistry 28 (13), 115525, 2020
322020
Application of the dual-tail approach for the design and synthesis of novel Thiopyrimidine–Benzenesulfonamide hybrids as selective carbonic anhydrase inhibitors
HT Abdel-Mohsen, AM El Kerdawy, MA Omar, A Petreni, RM Allam, ...
European Journal of Medicinal Chemistry 228, 114004, 2022
302022
Design, synthesis, and molecular docking of novel 2‐arylbenzothiazole multiangiokinase inhibitors targeting breast cancer
HT Abdel‐Mohsen, EA Abd El‐Meguid, AM El Kerdawy, AEE Mahmoud, ...
Archiv der Pharmazie 353 (4), 1900340, 2020
302020
Some 1, 3, 5-trisubstituted pyrazoline derivatives targeting breast cancer: Design, synthesis, cytotoxic activity, EGFR inhibition and molecular docking
RF George, M Kandeel, DY El-Ansary, AM El Kerdawy
Bioorganic Chemistry 99, 103780, 2020
282020
Receptor-based pharmacophore modeling, virtual screening, and molecular docking studies for the discovery of novel GSK-3β inhibitors
AM El Kerdawy, AA Osman, MA Zaater
Journal of Molecular Modeling 25, 1-21, 2019
282019
The system can't perform the operation now. Try again later.
Articles 1–20